NYU's Dr. Pillinger talks about Dr. Ann Rosenthal's state of the art talk on calcium pyrophosphate disease at ACR 2020.
Dr. Janet Pope reviews abstract #1466 presented at the 2020 ACR annual meeting. Who has more comorbidities: OA, Gout, RA or PsA?
Dr. Robert Chao reviews abstracts #1498, #1323 and #1324 presented at the 2020 ACR annual meeting.
Dr. Conway discusses late-breaking abstract #L06 presented Monday at the ACR 2020 annual meeting.
Dr. Jeff Curtis from UAB examines the use of Febuxostat (abstract L08) presented at the 2020 ACR annual meeting.
Dr. Janet Pope reviews abstract #1825 at the 2020 ACR annual meeting.
Dr. Cush interviews past ACR president and long-time friend Dr. Stan Cohen on treatment for liver disease in RA patients and new guidelines being released this morning at ACR 2020.
Dr. David Liew reviews abstracts #0516 and #0513 presented at the 2020 ACR annual meeting.
Dr. Antoni Chan reviews abstracts #1303 and #1306 presented at the ACR 2020 annual meeting.
They're back: from Dublin, Melbourne, Boston, Baltimore and Quezon City, Philippines to discuss top abstracts in the area of RA at the end of day three (Sunday) at ACR 2020, led by Dr. Jonathan Kay. Panelists: Dr. Sheila Reyes, Dr. David Liew, Dr. Eric Dein and Dr. Richard Conway.
Dr. Chan reviews several abstracts #1366, #1367 and #1364 at the 2020 ACR annual meeting.
Dr. Dalbeth examines abstracts #1466 and #0660 relating to the comorbidities in Gout at ACR 2020.
Dr. Monica Guma reviews her Monday abstract presentation on gut microbiome and improvement in RA (abstract #1994), being presented at the 2020 ACR annual meeting.
Dr. Eric Dein reviews abstract #1189 (from the PRECISION trial) presented at the 2020 ACR annual meeting.
Dr. Jack Cush interviews Dr. Petri about the comparative value of lupus anticoagulant vs. other antiphospholipid antibody tests and their role in CVA or MI - looking at abstracts #1261, #1262 and #1266 presented at the 2020 ACR Annual Meeting.